Skip to content

Exagen Inc. XGN Other current assets

Other current assets at other companies

Idexx Laboratories logo
Idexx LaboratoriesIDXX
$267.6M+16.3%
Vor Biopharma logo
Vor BiopharmaVOR
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Revvity logo
RevvityRVTY
Agilent Technologies logo
Agilent TechnologiesA
Biodesix, Inc. logo
Biodesix, Inc.BDSX

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s other current assets?
Exagen Inc. (XGN) reported other current assets of $4.1M in Q1 2026.
How has Exagen Inc.'s other current assets changed year-over-year?
Exagen Inc.'s other current assets decreased by 13.7% year-over-year, from $4.75M to $4.1M.
What is the long-term trend for Exagen Inc.'s other current assets?
Over 5 years (2020 to 2025), Exagen Inc.'s other current assets has grown at a 22.3% compound annual growth rate (CAGR), from $1.2M to $3.3M.